 |
|
|
| |
Sofosbuvir/velpatasvir/voxilaprevir(SOF/VEL/VOX) in care of chronic hepatitis C patients; clinical practice experience from the TRIO network
|
| |
| |
Reported by Jules Levin
AASLD 2018 Nov 9-13 San Francisco
Bruce Bacon1, Michael Curry2, Steven L. Flamm3, Scott Milligan4, NaokyTsai5, Nicole Wick4, Zobair Younossi6and Nezam Afdhal2
1Saint Louis University School of Medicine, 2Beth Israel Deaconess Medical Center,3Northwestern University Feinberg School of Medicine, 4Trio Health Analytics, 5University of Hawaii, and 6Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital
|
| |
|
|
|
|
|
